142 related articles for article (PubMed ID: 21633633)
1. Phase I and Phase II clinical trials of androst-5-ene-3β,7β,17β-triol.
Stickney DR; Ahlem CN; Morgan E; Reading CL; Onizuka N; Frincke JM
Am J Transl Res; 2011 May; 3(3):275-83. PubMed ID: 21633633
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology and immune modulating properties of 5-androstene-3β,7β,17β-triol, a DHEA metabolite in the human metabolome.
Ahlem CN; Auci DL; Nicoletti F; Pieters R; Kennedy MR; Page TM; Reading CL; Enioutina EY; Frincke JM
J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):87-94. PubMed ID: 21570467
[TBL] [Abstract][Full Text] [Related]
3. Androst-5-ene-3β,7α/β,17β-triols, their plasma levels and dependence on the hypothalamic-pituitary-adrenal axis.
Stárka L; Hill M; Kolatorova L; Dušková M
Steroids; 2018 Jun; 134():88-95. PubMed ID: 29477344
[TBL] [Abstract][Full Text] [Related]
4. Studies of the pharmacology of 17α-ethynyl-androst-5-ene-3β,7β,17β-triol, a synthetic anti-inflammatory androstene.
Ahlem CN; Kennedy MR; Page TM; Reading CL; White SK; McKenzie JJ; Cole PI; Stickney DR; Frincke JM
Int J Clin Exp Med; 2011; 4(2):119-35. PubMed ID: 21686136
[TBL] [Abstract][Full Text] [Related]
5. 17α-Ethynyl-androst-5-ene-3β,7β,17β-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of Parkinson's Disease.
Nicoletti F; Philippens I; Fagone P; Ahlem CN; Reading CL; Frincke JM; Auci DL
Parkinsons Dis; 2012; 2012():969418. PubMed ID: 23050197
[TBL] [Abstract][Full Text] [Related]
6. Biotransformation of dehydroepiandrosterone with Macrophomina phaseolina and β-glucuronidase inhibitory activity of transformed products.
Choudhary MI; Zafar S; Khan NT; Ahmad S; Noreen S; Marasini BP; Al-Khedhairy AA; Atta-Ur-Rahman
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):348-55. PubMed ID: 21774747
[TBL] [Abstract][Full Text] [Related]
7. Safety and pharmacokinetic study with escalating doses of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy male volunteers.
Davidson M; Marwah A; Sawchuk RJ; Maki K; Marwah P; Weeks C; Lardy H
Clin Invest Med; 2000 Oct; 23(5):300-10. PubMed ID: 11055323
[TBL] [Abstract][Full Text] [Related]
8. Ergosteroids. VI. Metabolism of dehydroepiandrosterone by rat liver in vitro: a liquid chromatographic-mass spectrometric study.
Marwah A; Marwah P; Lardy H
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Feb; 767(2):285-99. PubMed ID: 11885858
[TBL] [Abstract][Full Text] [Related]
9. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
10. Formation of bile acids in man: conversion of cholesterol into 5-beta-cholestane-3-alpha, 7-alpha, 12-alpha-triol in liver homogenates.
Björkheim I; Danielsson H; Einarsson K; Johansson G
J Clin Invest; 1968 Jul; 47(7):1573-82. PubMed ID: 4385432
[TBL] [Abstract][Full Text] [Related]
11. Analytical strategies for the detection of non-labelled anabolic androgenic steroids in nutritional supplements.
Parr MK; Geyer H; Reinhart U; Schänzer W
Food Addit Contam; 2004 Jul; 21(7):632-40. PubMed ID: 15370836
[TBL] [Abstract][Full Text] [Related]
12. A Randomized, Single-Center, Double-Blind, Placebo-Controlled Multiple-Dose Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Imarikiren in Healthy Adult Nonelderly and Elderly Male Subjects.
Matsuno K; Tanaka S; Hashimoto T; Nakamichi H; Kagawa T; Koumura E
J Clin Pharmacol; 2018 Nov; 58(11):1516-1524. PubMed ID: 29733435
[TBL] [Abstract][Full Text] [Related]
13. Redox reactions of dehydroepiandrosterone and its metabolites in differentiating 3T3-L1 adipocytes: A liquid chromatographic-mass spectrometric study.
Marwah A; Gomez FE; Marwah P; Ntambi JM; Fox BG; Lardy H
Arch Biochem Biophys; 2006 Dec; 456(1):1-7. PubMed ID: 17078923
[TBL] [Abstract][Full Text] [Related]
14. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
15. Seized designer supplement named "1-Androsterone": identification as 3β-hydroxy-5α-androst-1-en-17-one and its urinary elimination.
Parr MK; Opfermann G; Geyer H; Westphal F; Sönnichsen FD; Zapp J; Kwiatkowska D; Schänzer W
Steroids; 2011 May; 76(6):540-7. PubMed ID: 21310167
[TBL] [Abstract][Full Text] [Related]
16. A UPLC-MS/MS method for quantification of 5α-androst-3β,5,6β-triol in human plasma: development, validation and its application in clinical pharmacokinetic study.
Wang Z; Wang H; Hu P; Jiang J; Zhao Q
Bioanalysis; 2017 Jun; 9(11):873-885. PubMed ID: 28617033
[TBL] [Abstract][Full Text] [Related]
17. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
18. Pituitary metabolism of 5alpha-androstane-3beta-17beta-diol: intense and rapid conversion into 5alpha-androstane-3beta,6alpha,17beta-triol and 5alpha-androstane-3beta,7alpha, 17beta-triol.
Guiraud JM; Morfin R; Ducouret B; Samperez S; Jouan P
Steroids; 1979 Sep; 34(3):241-8. PubMed ID: 494365
[TBL] [Abstract][Full Text] [Related]
19. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.
Chen J; Wang WQ; Lin SX
J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of candesartan after single and repeated doses of candesartan cilexetil in young and elderly healthy volunteers.
Hübner R; Högemann AM; Sunzel M; Riddell JG
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S19-25. PubMed ID: 9331000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
